Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Fact

Fact

posted on Feb 03, 2008 09:23AM

We seem to have lost some analyst support.

Looking at Vangaurd's WEB site today I find that "First Call Consensus" no longer rates PTSC a "Strong Buy".

First Call no longer has any rating for PTSC on Vangaurd's WEB site; "No First Call ratings data available".

 

Share
New Message
Please login to post a reply